Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.

Saved in:
Bibliographic Details
Title: Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.
Authors: Fauveau C; Transgene, 67400 Illkirch-Graffenstaden, France.; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France., Lawendy E; Transgene, 67400 Illkirch-Graffenstaden, France., Deforges J; Transgene, 67400 Illkirch-Graffenstaden, France., Cochin S; Transgene, 67400 Illkirch-Graffenstaden, France., Moreau B; Transgene, 67400 Illkirch-Graffenstaden, France., Balloul JM; Transgene, 67400 Illkirch-Graffenstaden, France., Erbs P; Transgene, 67400 Illkirch-Graffenstaden, France., Jain S; Transgene, 67400 Illkirch-Graffenstaden, France., Laverny G; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France.
Corporate Authors: PERSIST-SEQ Consortium
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Jun 19; Vol. 34 (3), pp. 201279. Date of Electronic Publication: 2026 Jun 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42438683
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fauveau+C%22">Fauveau C</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Lawendy+E%22">Lawendy E</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Deforges+J%22">Deforges J</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Cochin+S%22">Cochin S</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Moreau+B%22">Moreau B</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Balloul+JM%22">Balloul JM</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Erbs+P%22">Erbs P</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Jain+S%22">Jain S</searchLink>; Transgene, 67400 Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Laverny+G%22">Laverny G</searchLink>; Institute of Genetics and Molecular and Cellular Biology (IGBMC), 67404 Illkirch-Graffenstaden, France.; CNRS UMR 7104, 67404 Illkirch-Graffenstaden, France.; Inserm U1258, 67404 Illkirch-Graffenstaden, France.; University of Strasbourg, 67404 Illkirch-Graffenstaden, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PERSIST-SEQ+Consortium%22">PERSIST-SEQ Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2026 Jun 19; Vol. 34 (3), pp. 201279. <i>Date of Electronic Publication: </i>2026 Jun 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42438683
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2026.201279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 201279
    Titles:
      – TitleFull: Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fauveau C
      – PersonEntity:
          Name:
            NameFull: Lawendy E
      – PersonEntity:
          Name:
            NameFull: Deforges J
      – PersonEntity:
          Name:
            NameFull: Cochin S
      – PersonEntity:
          Name:
            NameFull: Moreau B
      – PersonEntity:
          Name:
            NameFull: Balloul JM
      – PersonEntity:
          Name:
            NameFull: Erbs P
      – PersonEntity:
          Name:
            NameFull: Jain S
      – PersonEntity:
          Name:
            NameFull: Laverny G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2026 Jun 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1